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inTrOducTiOn
Enzyme immunoassay (EIA) and enzyme-linked immunosor-
bent assay (ELISA) are both widely used as diagnostic tools in 
medicine and as quality control measures in various industries; 
they are also used as analytical tools in biomedical research 
for the detection and quantification of specific antigens or anti-
bodies in a given sample. These two procedures share similar 
basic principles and are derived from the radioimmunoassay 
(RIA). RIA was first described by Berson and Yalow (Yalow and 
Berson, 1960), for which Yalow was awarded the Nobel Prize 
in 1977, to measure endogenous plasma insulin. RIA was then 
developed into a novel technique to detect and measure bio-
logical molecules present in very small quantities, paving the 
way for the analysis and detection of countless other biologi-
cal molecules, including hormones, peptides, and proteins. 
Because of the safety concern regarding its use of radioactivity, 
RIA assays were modified by replacing the radioisotope with an 
enzyme, thus creating the modern-day EIA and ELISA.
General principles
EIA/ELISA uses the basic immunology concept of an antigen 
binding to its specific antibody, which allows detection of very 
small quantities of antigens such as proteins, peptides, hor-
mones, or antibody in a fluid sample. EIA and ELISA utilize 
enzyme-labeled antigens and antibodies to detect the bio-
logical molecules, the most commonly used enzymes being 
alkaline phosphatase (EC 3.1.3.1) and glucose oxidase (E.C. 
1.1.3.4). The antigen in fluid phase is immobilized, usually in 
96-well microtiter plates. The antigen is allowed to bind to a 
specific antibody, which is itself subsequently detected by a 
secondary, enzyme-coupled antibody. A chromogenic sub-
strate for the enzyme yields a visible color change or fluores-
cence, indicating the presence of antigen. Quantitative or 
qualitative measures can be assessed based on such colorimet-
ric reading. Fluorogenic substrates have higher sensitivity and 
can accurately measure levels of antigen concentrations in the 
sample. The general procedure for ELISA is outlined in Figure 1.
Various types of ELISAs have been employed with modifica-
tion to the basic steps described in Figure 1. The key step in 
the ELISA assay is the direct or indirect detection of antigen by 
adhering or immobilizing the antigen or antigen-specific cap-
ture antibody, respectively, directly onto the well surface. For 
sensitive and robust measurements, the antigen can be spe-
cifically selected out from a sample of mixed antigens via a 
WHAT ENZYME-LINKED 
IMMUNOSORBENT ASSAY (ELISA) DOES
•  ELISA is a biochemical assay that uses antibodies 
and an enzyme-mediated color change to detect 
the presence of either antigen (proteins, peptides, 
hormones, etc.) or antibody in a given sample.
•  Both “indirect” and “sandwich” ELISAs allow 
detection of antigen or antibody at very low 
concentrations.
•  The competitive method detects compositional 
differences in complex antigen mixtures with 
high sensitivity, even when the specific detecting 
antibody is present in relatively small amounts.
•  Multiple and portable ELISA is a ready-to-use, 
low-cost lab kit that is ideal for large population 
screening in low-resource settings.
LIMITATIONS 
•  The enzyme-mediated color change will react 
indefinitely. Over a sufficiently long period of time, 
the color strength will inaccurately reflect the 
amount of primary antibody present, yielding false-
positive results.
•  To detect a given antibody or antigen, a known 
reciprocal antigen or antibody must be generated.
•  Nonspecific binding of the antibody or antigen to 
the plate will lead to a falsely high-positive result.
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to the specific test antigen to select it out of the serum, as 
illustrated in the sandwich technique below.
sandwich elisa
The sandwich technique is used to identify a specific sample anti-
gen. The well surface is prepared with a known quantity of bound 
antibody to capture the desired antigen. After nonspecific binding 
sites are blocked using bovine serum albumin, the antigen-con-
taining sample is applied to the plate. A specific primary antibody 
is then added that “sandwiches” the antigen. Enzyme-linked sec-
ondary antibodies are applied that bind to the primary antibody. 
Unbound antibody–enzyme conjugates are washed off. Substrate 
is added and is enzymatically converted to a color that can be 
later quantified. Canady et al. (2013) analyzed patient sera using 
the sandwich method to detect enhanced keratinocyte growth 
factor (KGF) levels in the sera of keloid and scleroderma patients 
compared to healthy controls to quantify human KGF (Figure 3).
One advantage of using a purified specific antibody to capture 
antigen is that it eliminates the need to purify the antigen from a 
mixture of other antigens, thus simplifying the assay and increas-
ing its specificity and sensitivity.
competitive elisa
The key event of competitive ELISA is the process of competi-
tive reaction between the sample antigen and antigen bound 
to the wells of a microtiter plate with the primary antibody. 
First, the primary antibody is incubated with the sample anti-
gen and the resulting antibody–antigen complexes are added 
to wells that have been coated with the same antigen. After 
an incubation period, any unbound antibody is washed off. 
The more antigen in the sample, the more primary antibody 
will be bound to the sample antigen. Therefore, there will be 
a smaller amount of primary antibody available to bind to the 
antigen coated on the well. Secondary antibody conjugated to 
an enzyme is added, followed by a substrate to elicit a chro-
mogenic or fluorescent signal. Absence of color indicates the 
presence of antigen in the sample.
The main advantage of competition ELISA is its high sensitivity 
to compositional differences in complex antigen mixtures, even 
when the specific detecting antibody is present in relatively small 
amounts (Dobrovolskaia et al., 2006). This method can be used 
to determine the potency of U.S. standardized allergen extracts 
(Dobrovolskaia et al., 2006) and to measure the total antibodies 
to the capsular polysaccharide of Haemophilus influenzae type 
“capture” antibody. The antigen is thus “sandwiched” between 
such capture antibody and a detection antibody. If the anti-
gen to be measured is small in size or has only one epitope 
for antibody binding, a competitive method is used in which 
either the antigen is labeled and competes for the unlabeled 
antigen–antibody complex formation or the antibody is labeled 
and competes for the bound antigen and antigen in the sample. 
Each of these modified techniques of ELISA can be used for a 
qualitative and quantitative purpose.
TYpes OF elisa
indirect elisa
A sample that must be analyzed for a specific antigen is adhered 
to the wells of a microtiter plate, followed by a solution of nonre-
acting protein such as bovine serum albumin to block any areas 
of the wells not coated with the antigen. The primary antibody, 
which binds specifically to the antigen, is then added, followed 
by an enzyme-conjugated secondary antibody. A substrate 
for the enzyme is introduced to quantify the primary antibody 
through a color change. The concentration of primary antibody 
present in the serum directly correlates with the intensity of the 
color. One application of the indirect ELISA method is demon-
strated by Haapakoski et al. (2013), who investigated the role 
of Toll-like receptor activation during cutaneous allergen sen-
sitization using ovalbumin (OVA) in the modulation of allergic 
asthma. In one experiment, dermal exposure to Toll-like receptor 
ligands (lipopolysaccharide, Pam3Cys, P(I:C)) was demonstrated 
to downregulate OVA-specific IgE antibodies in serum, as mea-
sured by the indirect ELISA technique (Figure 2).
A main disadvantage of indirect ELISA is that the meth-
od of antigen immobilization is not specific. When serum 
is used as the test antigen, all proteins in the sample may 
adhere to the wells of a microtiter plate. This limitation, 
however, can be overcome using a capture antibody unique 
Figure 1. enzyme-linked immunosorbent assay (elisa) technique used 
to detect an antigen in a given sample. The antigen (in liquid phase) is 
added to the wells, where it adheres to the walls. Primary antibody binds 
specifically to the antigen. An enzyme-linked secondary antibody is added 
that reacts with a chromogen, producing a color change to quantitatively or 
qualitatively detect the antigen.
Figure 2. indirect enzyme-linked immunosorbent assay (elisa). Dermal 
exposure to Toll-like receptor ligands (lipopolysaccharide, Pam3Cys, P(I:C)) 
was demonstrated to downregulate ovalbumin-specific IgE antibodies 
in serum, as measured by the indirect ELISA technique. Reprinted from 
Haapakoski et al. (2013).
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b in human sera from vaccinated subjects (Mariani et al., 1998). 
Competitive ELISA is often used to detect HIV antibodies in the 
sera of patients. The HIV antigen is coated on the surface of the 
microtiter plate wells, and two specific antibodies are applied: 
one conjugated with enzyme and the other of the sera of the 
patient. Cumulative competition occurs between the two anti-
bodies for the same antigen. If antibodies are present in the sera, 
then the antigen–antibody reaction occurs, leaving behind very 
low amounts of antigen available for binding with the enzyme-
labeled antibody. Most of the unbound enzyme-labeled anti-
bodies are washed off, producing minimal to no color change. 
Absence of color is indicative of an HIV-positive sample.
multiple and portable elisa
Multiple and portable ELISA is a new technique that uses a mul-
ticatcher device with 8 or 12 immunosorbent protruding pins 
on a central stick that can be immersed in a collected sample. 
The washings and incubation with enzyme-conjugated antigens 
and chromogens are performed by dipping the pins in prefilled 
microwells with reagents. The main advantage of these ready-to-
use lab kits is that they are relatively inexpensive, can be used 
for large population screening, and do not require skilled per-
sonnel or laboratory equipment, making them an ideal tool for 
low-resource settings (Balsam et al., 2013). Clinical applications 
include point-of-care detection of infectious diseases, bacterial 
toxins, oncologic markers, and drug screening.
summarY
EIA/ELISA is a powerful method not only for general biomedi-
cal research but also as a diagnostic tool. It allows detection of 
all types of biological molecules at very low concentrations and 
quantities. Although it has its limitations, EIA/ELISA remains an 
important tool in both clinical and basic research, as well as in 
clinical diagnostics.
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Figure 3. sandwich enzyme-linked immunosorbent assay (elisa). The 
“sandwich” method was used to detect enhanced keratinocyte growth factor 
(KGF) levels in the sera of keloid and scleroderma patients compared to 
healthy controls to quantify human KGF. Reprinted from Canady et al. (2013).
1.  Which of the following molecule(s) can be detected 
by elisa?
A.  Proteins.
B.  Hormones.
C.  Antibodies.
D.  All of the above.
2.  What does a weak color signal in competitive elisa 
represent?
A.  More antigen in the sample.
B.  Less antigen in the sample.
C. Less antigen retained on the well.
D.  Both a and c.
3.  Which of the following is immobilized on the 
microtiter well in sandwich elisa?
A.  Detection antibody.
B.  Sample.
C. Capture antibody.
D. Secondary antibody conjugated to an enzyme.
4.  What is a major advantage of elisa in comparison 
to other biological quantification techniques?
A.  Detection of a molecule at a low concentration.
B. Inexpensive.
C. Low specificity.
D. Easily available.
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